Concepedia

Elliot Ehrich

EE

Statistics

Publications

38

Citations

4.8K

H-Index

30

Active since

1986

Affiliations

Alkermes (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Alkermes (Ireland)

University of Toronto

KU Leuven

Elliot Ehrich is an author at Alkermes (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1986–2019

38

Publications

38

Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence

James C. Garbutt, Henry R. Kranzler, Stephanie S. O’Malley et al. · JAMA · 2005 · 624 citations

, , +15

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.

Elliot Ehrich, David J. Watson, James A. Bolognese et al. · PubMed · 2000 · 433 citations

, , +17

The nature of major histocompatibility complex recognition by γδ T cells

Hansjörg Schild, Nasim Mavaddat, Christa Litzenberger et al. · Cell · 1994 · 403 citations

, , +11

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Elliot Ehrich, A. Dallob, I Delepeleire et al. · Clinical Pharmacology & Therapeutics · 1999 · 326 citations

, , +16

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

Christine Brideau, Stacia Kargman, S. Liu et al. · Inflammation Research · 1996 · 281 citations

, , +17

1–5 of 38